☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Evolus
Evolus Reports Premarket Approval Application Submission to the US FDA for Evolysse Dermal Filler Products
June 25, 2024
Rui Avelar, CMO and Head of R&D at Evolus Shares Insights from Interim P-II Data Results Evaluating an "Extra-Strength" Formulatio...
June 13, 2023
PharmaShots' Most Read News of 2019
January 10, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
